Ondrej Dolezal, MD, PhD, FRCP (Edin)
Ondrej Dolezal, MD, PhD, FRCP (Edin)
NHS Scotland, Dumfries & Galloway Royal Infirmary
Verified email at nhs.net
Cited by
Cited by
Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis
N Bergsland, D Horakova, MG Dwyer, O Dolezal, ZK Seidl, M Vaneckova, ...
American Journal of Neuroradiology 33 (8), 1573-1578, 2012
Spektrum poruch příjmu potravy: interdisciplinární přístup
P Hana
Grada Publishing as, 2010
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis
E Havrdova, R Zivadinov, J Krasensky, MG Dwyer, I Novakova, O Dolezal, ...
Multiple Sclerosis Journal 15 (8), 965-976, 2009
Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis: a 5-year longitudinal study
D Horakova, MG Dwyer, E Havrdova, JL Cox, O Dolezal, N Bergsland, ...
Journal of the neurological sciences 282 (1-2), 112-119, 2009
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study
D Horakova, JL Cox, E Havrdova, S Hussein, O Dolezal, D Cookfair, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (4), 407-414, 2008
Clinical correlates of grey matter pathology in multiple sclerosis
D Horakova, T Kalincik, JB Dusankova, O Dolezal
BMC neurology 12 (1), 1-10, 2012
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years
R Zivadinov, N Bergsland, O Dolezal, S Hussein, Z Seidl, MG Dwyer, ...
American Journal of Neuroradiology 34 (10), 1931-1939, 2013
Is it possible to actively and purposely make use of plasticity and adaptability in the neurorehabilitation treatment of multiple sclerosis patients? A pilot project
K Rasova, J Krasensky, E Havrdova, J Obenberger, Z Seidel, O Dolezal, ...
Clinical Rehabilitation 19 (2), 170-181, 2005
Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis
O Dolezal, MG Dwyer, D Horakova, E Havrdova, A Minagar, ...
International review of neurobiology 79, 475-489, 2007
Early predictors of non‐response to interferon in multiple sclerosis
D Horakova, T Kalincik, O Dolezal, J Krasensky, M Vaneckova, Z Seidl, ...
Acta neurologica scandinavica 126 (6), 390-397, 2012
Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort
T Kalincik, D Horakova, O Dolezal, J Krasensky, M Vaneckova, Z Seidl, ...
Clinical neurology and neurosurgery 114 (7), 940-946, 2012
Patients’ stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis
M Vaneckova, Z Seidl, J Krasensky, E Havrdova, D Horakova, O Dolezal, ...
European neurology 61 (5), 278-284, 2009
Sphenopalatine ganglion stimulation to augment cerebral blood flow: a randomized, sham-controlled trial
NM Bornstein, JL Saver, HC Diener, PB Gorelick, A Shuaib, Y Solberg, ...
Stroke 50 (8), 2108-2117, 2019
Bimonthly evolution of cortical atrophy in early relapsing-remitting multiple sclerosis over 2 years: a longitudinal study
R Zivadinov, C Tekwe, N Bergsland, O Dolezal, E Havrdova, J Krasensky, ...
Multiple sclerosis international 2013, 2013
Serious complication of percutaneous angioplasty with stent implantation in so called “chronic cerebrospinal venous insufficiency” in multiple sclerosis patient
O Dolezal, D Horakova, Z Gdovinova, J Szilasiova
Prague Med Rep 113 (4), 289-93, 2012
Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study
D Horáková, M Kýr, E Havrdová, O Doležal, P Lelková, L Pospíšilová, ...
Folia Biol (Praha) 56 (6), 242-51, 2010
The neurobiology of multiple sclerosis
A Minagar
Academic Press, 2007
Development of gray matter atrophy in relapsing–remitting multiple sclerosis is not gender dependent: Results of a 5-year follow-up study
O Dolezal, T Gabelic, D Horakova, N Bergsland, MG Dwyer, Z Seidl, ...
Clinical neurology and neurosurgery 115, S42-S48, 2013
Intramuscular interferon beta-1a, azathioprine, and corticosterold combination therapy in patients with relapsing-remitting multiple sclerosis: 5-year clinical efficacy results
E Havrdova, R Zivadinov, J Krasensky, M Dwyer, I Novakova, O Dolezal, ...
Neurology 68 (12), A277-A277, 2007
Efficacy results from a randomised, double-blind, placebo-controlled study of intramuscular interferon beta-1a, azathioprine, and corticosteroid combination therapy in patients …
E Havrdova, R Zivadinov, J Krasensky, MG Dwyer, I Novakova, A Dolezal, ...
The system can't perform the operation now. Try again later.
Articles 1–20